North America Antimicrobial Susceptibility Testing Market _Companies Profiles, Size, Share, Growth, Trends and Forecast to 2027
North America antimicrobial susceptibility testing market is expected to grow with a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Prominent factors driving the growth of this market consist of an Increase in the number of infectious diseases, technological advancements in antimicrobial susceptibility methods, Increased funding, research grants, and public-private investments. Other factor propelling market growth Includes the emergence of multidrug resistance due to drug abuse.
The key market players for North America antimicrobial susceptibility testing market are listed below:
On the basis of methods North America antimicrobial susceptibility testing market is segmented into dilution methods, disk diffusion method, E-test, genotypic methods, automated systems. In 2018, disk diffusion method segment is expected to dominate the North America antimicrobial susceptibility testing market with the highest market share in the forecast period 2018 to 2025.
On the basis of application North America antimicrobial susceptibility testing market is segmented into clinical diagnostics, drug discovery and development, epidemiology, others. In 2018, clinical diagnostics segment is expected to dominate the North America antimicrobial susceptibility testing market with the highest CAGR in the forecast period 2018 to 2025.
On the basis of end user the North America antimicrobial susceptibility testing market is segmented into hospitals, pharmaceutical and biotechnology companies, diagnostic laboratories, research and academic institutes, contract research organizations. In 2018, hospitals segment is expected to dominate the North America antimicrobial susceptibility testing market with 28.9% market shares in the forecast period 2018 to 2025.
Based on geography, the market is segmented into 3 Geographic al regions:
The report covers the present scenario and the growth prospects of the North America antimicrobial susceptibility testing market for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Prominent factors driving the growth of this market consist of an Increase in the number of infectious diseases, technological advancements in antimicrobial susceptibility methods, Increased funding, research grants, and public-private investments. Other factor propelling market growth Includes the emergence of multidrug resistance due to drug abuse.
The key market players for North America antimicrobial susceptibility testing market are listed below:
- bioMérieux SA
- Thermo Fisher Scientific
- BD
- Bio-Rad Laboratories, Inc.
- HiMedia Laboratories.
- Liofilchem S.r.l.
- Accelerate Diagnostics, Inc.
- Alifax Holding S.p.A.
- Merck & Co., Inc.
- Bioanalyse Tibbi Malz. Singing. and Tic. Ltd. Sti.
- Creative Diagnostics.
- Genefluidics, Inc.
- Conda,
- Zhuhai DL Biotech. Co.
- Product
- Methods
- Application
- End User
On the basis of methods North America antimicrobial susceptibility testing market is segmented into dilution methods, disk diffusion method, E-test, genotypic methods, automated systems. In 2018, disk diffusion method segment is expected to dominate the North America antimicrobial susceptibility testing market with the highest market share in the forecast period 2018 to 2025.
On the basis of application North America antimicrobial susceptibility testing market is segmented into clinical diagnostics, drug discovery and development, epidemiology, others. In 2018, clinical diagnostics segment is expected to dominate the North America antimicrobial susceptibility testing market with the highest CAGR in the forecast period 2018 to 2025.
On the basis of end user the North America antimicrobial susceptibility testing market is segmented into hospitals, pharmaceutical and biotechnology companies, diagnostic laboratories, research and academic institutes, contract research organizations. In 2018, hospitals segment is expected to dominate the North America antimicrobial susceptibility testing market with 28.9% market shares in the forecast period 2018 to 2025.
Based on geography, the market is segmented into 3 Geographic al regions:
- U.S.
- Canada
- Mexico
The report covers the present scenario and the growth prospects of the North America antimicrobial susceptibility testing market for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
1 INTRODUCTION
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of North America Antimicrobial Susceptibility Testing Market
1.4 Currency And Pricing
1.5 Limitation
1.6 Markets Covered
2 MARKET SEGMENTATION
2.1 Markets Covered
2.2 Geographic Scope
2.3 Years Considered For The Study
2.4 Currency And Pricing
2.5 Research Methodology
2.6 Primary Interviews With Key Opinion Leaders
2.7 The Category Vs Time Grid
2.8 DBMR Market Challenge Matrix
2.9 Secondary Sources
2.10 Assumptions
3 MARKET OVERVIEW
3.1 Drivers
3.1.1 Increase In Number Of Infectious Disease
3.1.2 Technological Advancements In Antimicrobial Susceptibility Methods
3.1.3 Emergence Of Multidrug Resistance Due To Multiple Drug Use
3.1.4 Increased Funding, Research Grants, And Public-Private Investments
3.2 Restraints
3.2.1 High Cost Of Automated Antimicrobial Susceptibility Testing Systems
3.3 Opportunities42
3.3.1 Emerging Markets To Offer Lucrative Opportunities
3.3.2 Increase Awareness To Detect And Control Antimicrobial Resistance
3.4 Challenges
3.4.1 Lack Of Coordination Between Regulatory Bodies, Clinical Laboratories, And Ast Manufacturers
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 NORTH AMERICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,
By Product
6.1 Overview
6.2 Manual
6.2.1 Susceptibility Testing Disks
6.2.2 Mic Strips
6.2.3 Susceptibility Plates
6.2.4 Antimicrobial Susceptibility Testing Culture Media
6.2.5 Consumables
6.3 Automated
6.3.1 Susceptibility Plates
6.3.2 Automated Instruments
6.3.3 Susceptibility Plate Ancillaries
7 NORTH AMERICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,
By Methods
7.1 Overview
7.2 Dilution Methods
7.3 Disk Diffusion Method
7.4 E- Test
7.5 Genotypic Methods
7.6 Automated Systems
8 NORTH AMERICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,
By Application
8.1 Overview
8.2 Clinical Diagnostics
8.3 Drug Discovery And Development
8.4 Epidemiology
8.5 Others
9 NORTH AMERICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,
By End User
9.1 Overview
9.2 Hospitals
9.3 Pharmaceutical And Biotechnology Companies
9.4 Diagnostic Laboratories
9.5 Research And Academic Institutes
9.6 Contract Research Organizations
10 NORTH AMERICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,
By Geography
10.1 North America
10.1.1 U.S.
10.1.2 Canada
10.1.3 Mexico
11 NORTH AMERICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,
Company Landscape
11.1 Company Share Analysis: North America
12 COMPANY PROFILES
12.1 Biomérieux Sa Company
12.1.1 Overview
12.1.2 Revenue Analysis
12.1.3 Company Share Analysis
12.1.4 Product Portfolio
12.1.5 Recent Developments
12.2 Thermo Fisher Scientific Inc.
12.2.1 Company Overview
12.2.2 Revenue Analysis
12.2.3 Company Share Analysis
12.2.4 Product Portfolio
12.2.5 Recent Developments
12.3 Bd
12.3.1 Company Overview
12.3.2 Revenue Analysis
12.3.3 Company Share Analysis
12.3.4 Product Portfolio
12.3.5 Recent Developments
12.4 Accelerate Diagnostics, Inc.
12.4.1 Company Overview
12.4.2 Revenue Analysis
12.4.3 Product Portfolio
12.4.4 Recent Developments
12.5 Alifax Holding S.P.A.
12.5.1 Company Overview
12.5.2 Geographic Presence
12.5.3 Product Portfolio
12.5.4 Recent Developments
12.6 Bio-Rad Laboratories Inc.
12.6.1 Company Overview
12.6.2 Revenue Analysis
12.6.3 Product Portfolio
12.6.4 Recent Developments
12.7 Bioanalyse Tibbi Malz. San. Ve Tic. Ltd. Sti.
12.7.1 Company Overview
12.7.2 Product Portfolio
12.7.3 Recent Developments
12.8 Conda
12.8.1 Company Overview
12.8.2 Geographic Presence
12.8.3 Product Portfolio
12.8.4 Recent Developments
12.9 Creative Diagnostics
12.9.1 Company Overview
12.9.2 Geographic Presence
12.9.3 Product Portfolio
12.9.4 Recent Developments
12.10 Genefluidics Inc.128
12.10.1 Company Overview
12.10.2 Product Portfolio
12.10.3 Recent Developments
12.11 Himedia Laboratories
12.11.1 Company Overview
12.11.2 Geographic al Presence
12.11.3 Product Portfolio
12.11.4 Recent Developments
12.12 Liofilchem Srl.
12.12.1 Company Overview
12.12.2 Product Portfolio
12.12.3 Recent Developments
12.13 Merck Millipore
12.13.1 Company Overview
12.13.2 Geographic Presence
12.13.3 Product Portfolio
12.13.4 Recent Developments
12.14 Zhuhai Dl Biotech. Co., Ltd
12.14.1 Company Overview
12.14.2 Product Portfolio
12.14.3 Recent Developments
13 RELATED REPORTS
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of North America Antimicrobial Susceptibility Testing Market
1.4 Currency And Pricing
1.5 Limitation
1.6 Markets Covered
2 MARKET SEGMENTATION
2.1 Markets Covered
2.2 Geographic Scope
2.3 Years Considered For The Study
2.4 Currency And Pricing
2.5 Research Methodology
2.6 Primary Interviews With Key Opinion Leaders
2.7 The Category Vs Time Grid
2.8 DBMR Market Challenge Matrix
2.9 Secondary Sources
2.10 Assumptions
3 MARKET OVERVIEW
3.1 Drivers
3.1.1 Increase In Number Of Infectious Disease
3.1.2 Technological Advancements In Antimicrobial Susceptibility Methods
3.1.3 Emergence Of Multidrug Resistance Due To Multiple Drug Use
3.1.4 Increased Funding, Research Grants, And Public-Private Investments
3.2 Restraints
3.2.1 High Cost Of Automated Antimicrobial Susceptibility Testing Systems
3.3 Opportunities42
3.3.1 Emerging Markets To Offer Lucrative Opportunities
3.3.2 Increase Awareness To Detect And Control Antimicrobial Resistance
3.4 Challenges
3.4.1 Lack Of Coordination Between Regulatory Bodies, Clinical Laboratories, And Ast Manufacturers
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 NORTH AMERICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,
By Product
6.1 Overview
6.2 Manual
6.2.1 Susceptibility Testing Disks
6.2.2 Mic Strips
6.2.3 Susceptibility Plates
6.2.4 Antimicrobial Susceptibility Testing Culture Media
6.2.5 Consumables
6.3 Automated
6.3.1 Susceptibility Plates
6.3.2 Automated Instruments
6.3.3 Susceptibility Plate Ancillaries
7 NORTH AMERICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,
By Methods
7.1 Overview
7.2 Dilution Methods
7.3 Disk Diffusion Method
7.4 E- Test
7.5 Genotypic Methods
7.6 Automated Systems
8 NORTH AMERICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,
By Application
8.1 Overview
8.2 Clinical Diagnostics
8.3 Drug Discovery And Development
8.4 Epidemiology
8.5 Others
9 NORTH AMERICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,
By End User
9.1 Overview
9.2 Hospitals
9.3 Pharmaceutical And Biotechnology Companies
9.4 Diagnostic Laboratories
9.5 Research And Academic Institutes
9.6 Contract Research Organizations
10 NORTH AMERICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,
By Geography
10.1 North America
10.1.1 U.S.
10.1.2 Canada
10.1.3 Mexico
11 NORTH AMERICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,
Company Landscape
11.1 Company Share Analysis: North America
12 COMPANY PROFILES
12.1 Biomérieux Sa Company
12.1.1 Overview
12.1.2 Revenue Analysis
12.1.3 Company Share Analysis
12.1.4 Product Portfolio
12.1.5 Recent Developments
12.2 Thermo Fisher Scientific Inc.
12.2.1 Company Overview
12.2.2 Revenue Analysis
12.2.3 Company Share Analysis
12.2.4 Product Portfolio
12.2.5 Recent Developments
12.3 Bd
12.3.1 Company Overview
12.3.2 Revenue Analysis
12.3.3 Company Share Analysis
12.3.4 Product Portfolio
12.3.5 Recent Developments
12.4 Accelerate Diagnostics, Inc.
12.4.1 Company Overview
12.4.2 Revenue Analysis
12.4.3 Product Portfolio
12.4.4 Recent Developments
12.5 Alifax Holding S.P.A.
12.5.1 Company Overview
12.5.2 Geographic Presence
12.5.3 Product Portfolio
12.5.4 Recent Developments
12.6 Bio-Rad Laboratories Inc.
12.6.1 Company Overview
12.6.2 Revenue Analysis
12.6.3 Product Portfolio
12.6.4 Recent Developments
12.7 Bioanalyse Tibbi Malz. San. Ve Tic. Ltd. Sti.
12.7.1 Company Overview
12.7.2 Product Portfolio
12.7.3 Recent Developments
12.8 Conda
12.8.1 Company Overview
12.8.2 Geographic Presence
12.8.3 Product Portfolio
12.8.4 Recent Developments
12.9 Creative Diagnostics
12.9.1 Company Overview
12.9.2 Geographic Presence
12.9.3 Product Portfolio
12.9.4 Recent Developments
12.10 Genefluidics Inc.128
12.10.1 Company Overview
12.10.2 Product Portfolio
12.10.3 Recent Developments
12.11 Himedia Laboratories
12.11.1 Company Overview
12.11.2 Geographic al Presence
12.11.3 Product Portfolio
12.11.4 Recent Developments
12.12 Liofilchem Srl.
12.12.1 Company Overview
12.12.2 Product Portfolio
12.12.3 Recent Developments
12.13 Merck Millipore
12.13.1 Company Overview
12.13.2 Geographic Presence
12.13.3 Product Portfolio
12.13.4 Recent Developments
12.14 Zhuhai Dl Biotech. Co., Ltd
12.14.1 Company Overview
12.14.2 Product Portfolio
12.14.3 Recent Developments
13 RELATED REPORTS
LIST OF TABLES
Table 1 North America Antimicrobial Susceptibility Testing Market, By Product, 2016-2025, (USD Million)
Table 2 North America Manual Antimicrobial Susceptibility Testing Market, By Product, 2016-2025 (USD Million)
Table 3 North America Manual Antimicrobial Susceptibility Testing Market, By Region, 2016-2025 (USD Million)
Table 4 North America Automated Antimicrobial Susceptibility Testing Market, By Product, 2016-2025 (USD Million)
Table 5 North America Automated Antimicrobial Susceptibility Testing Market, By Region, 2016-2025 (USD Million)
Table 6 North America Antimicrobial Susceptibility Testing Market, By Methods, 2016-2025, (USD Million)
Table 7 North America Dilution Methods In Antimicrobial Susceptibility Testing Market, By Region, USD Million (2016 -2025)
Table 8 North America Disk Diffusion Method In Antimicrobial Susceptibility Testing Market, By Region, USD Million (2016 -2025)
Table 9 North America E- Test In Antimicrobial Susceptibility Testing Market, By Region, USD Million (2016 -2025)
Table 10 North America Genotypic Methods In Antimicrobial Susceptibility Testing Market, By Region, USD Million (2016 -2025)
Table 11 North America Automated Systems In Antimicrobial Susceptibility Testing Market, By Region, USD Million (2016 -2025)
Table 12 North America Antimicrobial Susceptibility Testing Market, By Applications, 2016-2025, (USD Million)
Table 13 North America Clinical Diagnostic In Antimicrobial Susceptibility Testing Market, By Region, USD Million (2016 -2025)
Table 14 North America Drug Discovery And Development In Antimicrobial Susceptibility Testing Market, By Region, USD Million (2016 -2025)
Table 15 North America Epidemiology In Antimicrobial Susceptibility Testing Market, By Region, USD Million (2016 -2025)
Table 16 North America Others In Antimicrobial Susceptibility Testing Market, By Region, USD Million (2016 -2025)
Table 17 North America Antimicrobial Susceptibility Testing Market, By End User, 2016-2025, (USD Million)
Table 18 The Impact Of Hospital Antimicrobial Susceptibility Testing In U.S. (2005)
Table 19 North America Hospitals In Antimicrobial Susceptibility Testing Market, By Region, USD Million (2016 -2025)
Table 20 North America Pharmaceutical And Biotechnology Companies In Antimicrobial Susceptibility Testing Market, By Region, USD Million (2016 -2025)
Table 21 North America Diagnostic Laboratories In Antimicrobial Susceptibility Testing Market, By Region, USD Million (2016 -2025)
Table 22 North America Research And Academic Institutes In Antimicrobial Susceptibility Testing Market, By Region, USD Million (2016 -2025)
Table 23 North America Contract Research Organizations In Antimicrobial Susceptibility Testing Market, By Region, USD Million (2016 -2025)
Table 24 North America Antimicrobial Susceptibility Testing Market, By Country, 2016 – 2025(USD Million)
Table 25 North America Antimicrobial Susceptibility Testing Market, By Product, 2016-2025 (USD Million)
Table 26 North America Manual Antimicrobial Susceptibility Testing Market, By Product, 2016-2025 (USD Million)
Table 27 North America Automated Antimicrobial Susceptibility Testing Market, By Product, 2016-2025 (USD Million)
Table 28 North America Antimicrobial Susceptibility Testing Market, By Methods, 2016-2025 (USD Million)
Table 29 North America Antimicrobial Susceptibility Testing Market, By Application, 2016-2025 (USD Million)
Table 30 North America Antimicrobial Susceptibility Testing Market, By End User, 2016-2025 (USD Million)
Table 31 U.S. Antimicrobial Susceptibility Testing Market, By Product, 2016-2025 (USD Million)
Table 32 U.S. Manual Antimicrobial Susceptibility Testing Market, By Product, 2016-2025 (USD Million)
Table 33 U.S. Automated Antimicrobial Susceptibility Testing Market, By Product, 2016-2025 (USD Million)
Table 34 U.S. Antimicrobial Susceptibility Testing Market, By Methods, 2016-2025 (USD Million)
Table 35 U.S. Antimicrobial Susceptibility Testing Market, By Application, 2016-2025 (USD Million)
Table 36 U.S. Antimicrobial Susceptibility Testing Market, By End User, 2016-2025 (USD Million)
Table 37 Canada Antimicrobial Susceptibility Testing Market, By Product, 2016-2025 (USD Million)
Table 38 Canada Manual Antimicrobial Susceptibility Testing Market, By Product, 2016-2025 (USD Million)
Table 39 Canada Automated Antimicrobial Susceptibility Testing Market, By Product, 2016-2025 (USD Million)
Table 40 Canada Antimicrobial Susceptibility Testing Market, By Methods, 2016-2025 (USD Million)
Table 41 Canada Antimicrobial Susceptibility Testing Market, By Application, 2016-2025 (USD Million)
Table 42 Canada Antimicrobial Susceptibility Testing Market, By End User, 2016-2025 (USD Million)
Table 43 Mexico Antimicrobial Susceptibility Testing Market, By Product, 2016-2025 (USD Million)
Table 44 Mexico Manual Antimicrobial Susceptibility Testing Market, By Product, 2016-2025 (USD Million)
Table 45 Mexico Automated Antimicrobial Susceptibility Testing Market, By Product, 2016-2025 (USD Million)
Table 46 Mexico Antimicrobial Susceptibility Testing Market, By Methods, 2016-2025 (USD Million)
Table 47 Mexico Antimicrobial Susceptibility Testing Market, By Application, 2016-2025 (USD Million)
Table 48 Mexico Antimicrobial Susceptibility Testing Market, By End User, 2016-2025 (USD Million)
Table 1 North America Antimicrobial Susceptibility Testing Market, By Product, 2016-2025, (USD Million)
Table 2 North America Manual Antimicrobial Susceptibility Testing Market, By Product, 2016-2025 (USD Million)
Table 3 North America Manual Antimicrobial Susceptibility Testing Market, By Region, 2016-2025 (USD Million)
Table 4 North America Automated Antimicrobial Susceptibility Testing Market, By Product, 2016-2025 (USD Million)
Table 5 North America Automated Antimicrobial Susceptibility Testing Market, By Region, 2016-2025 (USD Million)
Table 6 North America Antimicrobial Susceptibility Testing Market, By Methods, 2016-2025, (USD Million)
Table 7 North America Dilution Methods In Antimicrobial Susceptibility Testing Market, By Region, USD Million (2016 -2025)
Table 8 North America Disk Diffusion Method In Antimicrobial Susceptibility Testing Market, By Region, USD Million (2016 -2025)
Table 9 North America E- Test In Antimicrobial Susceptibility Testing Market, By Region, USD Million (2016 -2025)
Table 10 North America Genotypic Methods In Antimicrobial Susceptibility Testing Market, By Region, USD Million (2016 -2025)
Table 11 North America Automated Systems In Antimicrobial Susceptibility Testing Market, By Region, USD Million (2016 -2025)
Table 12 North America Antimicrobial Susceptibility Testing Market, By Applications, 2016-2025, (USD Million)
Table 13 North America Clinical Diagnostic In Antimicrobial Susceptibility Testing Market, By Region, USD Million (2016 -2025)
Table 14 North America Drug Discovery And Development In Antimicrobial Susceptibility Testing Market, By Region, USD Million (2016 -2025)
Table 15 North America Epidemiology In Antimicrobial Susceptibility Testing Market, By Region, USD Million (2016 -2025)
Table 16 North America Others In Antimicrobial Susceptibility Testing Market, By Region, USD Million (2016 -2025)
Table 17 North America Antimicrobial Susceptibility Testing Market, By End User, 2016-2025, (USD Million)
Table 18 The Impact Of Hospital Antimicrobial Susceptibility Testing In U.S. (2005)
Table 19 North America Hospitals In Antimicrobial Susceptibility Testing Market, By Region, USD Million (2016 -2025)
Table 20 North America Pharmaceutical And Biotechnology Companies In Antimicrobial Susceptibility Testing Market, By Region, USD Million (2016 -2025)
Table 21 North America Diagnostic Laboratories In Antimicrobial Susceptibility Testing Market, By Region, USD Million (2016 -2025)
Table 22 North America Research And Academic Institutes In Antimicrobial Susceptibility Testing Market, By Region, USD Million (2016 -2025)
Table 23 North America Contract Research Organizations In Antimicrobial Susceptibility Testing Market, By Region, USD Million (2016 -2025)
Table 24 North America Antimicrobial Susceptibility Testing Market, By Country, 2016 – 2025(USD Million)
Table 25 North America Antimicrobial Susceptibility Testing Market, By Product, 2016-2025 (USD Million)
Table 26 North America Manual Antimicrobial Susceptibility Testing Market, By Product, 2016-2025 (USD Million)
Table 27 North America Automated Antimicrobial Susceptibility Testing Market, By Product, 2016-2025 (USD Million)
Table 28 North America Antimicrobial Susceptibility Testing Market, By Methods, 2016-2025 (USD Million)
Table 29 North America Antimicrobial Susceptibility Testing Market, By Application, 2016-2025 (USD Million)
Table 30 North America Antimicrobial Susceptibility Testing Market, By End User, 2016-2025 (USD Million)
Table 31 U.S. Antimicrobial Susceptibility Testing Market, By Product, 2016-2025 (USD Million)
Table 32 U.S. Manual Antimicrobial Susceptibility Testing Market, By Product, 2016-2025 (USD Million)
Table 33 U.S. Automated Antimicrobial Susceptibility Testing Market, By Product, 2016-2025 (USD Million)
Table 34 U.S. Antimicrobial Susceptibility Testing Market, By Methods, 2016-2025 (USD Million)
Table 35 U.S. Antimicrobial Susceptibility Testing Market, By Application, 2016-2025 (USD Million)
Table 36 U.S. Antimicrobial Susceptibility Testing Market, By End User, 2016-2025 (USD Million)
Table 37 Canada Antimicrobial Susceptibility Testing Market, By Product, 2016-2025 (USD Million)
Table 38 Canada Manual Antimicrobial Susceptibility Testing Market, By Product, 2016-2025 (USD Million)
Table 39 Canada Automated Antimicrobial Susceptibility Testing Market, By Product, 2016-2025 (USD Million)
Table 40 Canada Antimicrobial Susceptibility Testing Market, By Methods, 2016-2025 (USD Million)
Table 41 Canada Antimicrobial Susceptibility Testing Market, By Application, 2016-2025 (USD Million)
Table 42 Canada Antimicrobial Susceptibility Testing Market, By End User, 2016-2025 (USD Million)
Table 43 Mexico Antimicrobial Susceptibility Testing Market, By Product, 2016-2025 (USD Million)
Table 44 Mexico Manual Antimicrobial Susceptibility Testing Market, By Product, 2016-2025 (USD Million)
Table 45 Mexico Automated Antimicrobial Susceptibility Testing Market, By Product, 2016-2025 (USD Million)
Table 46 Mexico Antimicrobial Susceptibility Testing Market, By Methods, 2016-2025 (USD Million)
Table 47 Mexico Antimicrobial Susceptibility Testing Market, By Application, 2016-2025 (USD Million)
Table 48 Mexico Antimicrobial Susceptibility Testing Market, By End User, 2016-2025 (USD Million)
LIST OF FIGURES
Figure 1 North America Antimicrobial Susceptibility Testing Market: Segmentation
Figure 2 North America Antimicrobial Susceptibility Testing Market: Data Triangulation
Figure 3 North America Antimicrobial Susceptibility Testing Market: Droc Analysis
Figure 4 North America Antimicrobial Susceptibility Testing Market: Bottom Up Approach
Figure 5 North America Antimicrobial Susceptibility Testing Market: Top Down Approach
Figure 6 North America Antimicrobial Susceptibility Testing Market: Interview Demographics
Figure 7 North America Antimicrobial Susceptibility Testing Market: The Category Vs Time Grid
Figure 8 North America Antimicrobial Susceptibility Testing Market: The Market Challenge Matrix
Figure 9 Drivers, Restraints, Opportunities, And Challenges Of North America Antimicrobial Susceptibility Testing Market
Figure 10 North America Antimicrobial Susceptibility Testing Market: Segmentation
Figure 11 Increase In Number Of Infectious Disease And Technological Advancements In Antimicrobial Susceptibility Methods Are Expected To Drive The Market For Antimicrobial Susceptibility Testing In The Forecast Period 2018 To 2025
Figure 12 Manual Segment Is Expected To Account For The Largest Share Of The North America Antimicrobial Susceptibility Testing Market In 2018 & 2025
Figure 13 North America Antimicrobial Susceptibility Testing Market: By Product, 2017
Figure 14 North America Antimicrobial Susceptibility Testing Market: By Methods, 2017
Figure 15 North America Antimicrobial Susceptibility Testing Market: By Application, 2017
Figure 16 North America Antimicrobial Susceptibility Testing Market: By End User, 2017
Figure 17 North America Antimicrobial Susceptibility Testing Market Snapshot (2017)
Figure 18 North America Antimicrobial Susceptibility Testing Market: By Country (2017)
Figure 19 North America Antimicrobial Susceptibility Testing Market: By Country (2018 & 2025)
Figure 20 North America Antimicrobial Susceptibility Testing Market: By Country (2017 & 2025)
Figure 21 North America Antimicrobial Susceptibility Testing Market By Product (2018 - 2025)
Figure 22 North America Antimicrobial Susceptibility Testing Market: Company Share 2017 (%)
COMPANIES MENTIONED
bioMérieux SA
Thermo Fisher Scientific
BD
Bio-Rad Laboratories, Inc.
HiMedia Laboratories.
Liofilchem S.r.l.
Accelerate Diagnostics, Inc.
Alifax Holding S.p.A.
Merck & Co., Inc.
Bioanalyse Tibbi Malz. Singing. and Tic. Ltd. Sti.
Creative Diagnostics.
Genefluidics, Inc.
Conda,
Zhuhai DL Biotech. Co.
Figure 1 North America Antimicrobial Susceptibility Testing Market: Segmentation
Figure 2 North America Antimicrobial Susceptibility Testing Market: Data Triangulation
Figure 3 North America Antimicrobial Susceptibility Testing Market: Droc Analysis
Figure 4 North America Antimicrobial Susceptibility Testing Market: Bottom Up Approach
Figure 5 North America Antimicrobial Susceptibility Testing Market: Top Down Approach
Figure 6 North America Antimicrobial Susceptibility Testing Market: Interview Demographics
Figure 7 North America Antimicrobial Susceptibility Testing Market: The Category Vs Time Grid
Figure 8 North America Antimicrobial Susceptibility Testing Market: The Market Challenge Matrix
Figure 9 Drivers, Restraints, Opportunities, And Challenges Of North America Antimicrobial Susceptibility Testing Market
Figure 10 North America Antimicrobial Susceptibility Testing Market: Segmentation
Figure 11 Increase In Number Of Infectious Disease And Technological Advancements In Antimicrobial Susceptibility Methods Are Expected To Drive The Market For Antimicrobial Susceptibility Testing In The Forecast Period 2018 To 2025
Figure 12 Manual Segment Is Expected To Account For The Largest Share Of The North America Antimicrobial Susceptibility Testing Market In 2018 & 2025
Figure 13 North America Antimicrobial Susceptibility Testing Market: By Product, 2017
Figure 14 North America Antimicrobial Susceptibility Testing Market: By Methods, 2017
Figure 15 North America Antimicrobial Susceptibility Testing Market: By Application, 2017
Figure 16 North America Antimicrobial Susceptibility Testing Market: By End User, 2017
Figure 17 North America Antimicrobial Susceptibility Testing Market Snapshot (2017)
Figure 18 North America Antimicrobial Susceptibility Testing Market: By Country (2017)
Figure 19 North America Antimicrobial Susceptibility Testing Market: By Country (2018 & 2025)
Figure 20 North America Antimicrobial Susceptibility Testing Market: By Country (2017 & 2025)
Figure 21 North America Antimicrobial Susceptibility Testing Market By Product (2018 - 2025)
Figure 22 North America Antimicrobial Susceptibility Testing Market: Company Share 2017 (%)
COMPANIES MENTIONED
bioMérieux SA
Thermo Fisher Scientific
BD
Bio-Rad Laboratories, Inc.
HiMedia Laboratories.
Liofilchem S.r.l.
Accelerate Diagnostics, Inc.
Alifax Holding S.p.A.
Merck & Co., Inc.
Bioanalyse Tibbi Malz. Singing. and Tic. Ltd. Sti.
Creative Diagnostics.
Genefluidics, Inc.
Conda,
Zhuhai DL Biotech. Co.
